47 results
Page 2 of 3
424B3
cvy0mqky zjre4
19 Aug 21
Prospectus supplement
9:05pm
8-K/A
ko3djh64
16 Aug 21
Completion of Acquisition or Disposition of Assets
5:23pm
424B3
vl3 0810ut9bxpj4uk
12 Aug 21
Prospectus supplement
4:21pm
8-K
1y4zgp
22 Jul 21
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
4:13pm
425
cbj bz05g84upep
7 Jul 21
Business combination disclosure
4:11pm
424B3
ecjwvdke1b2nyo
25 Jun 21
Prospectus supplement
12:48pm
425
vtjsxg1xp64g
15 Jun 21
Business combination disclosure
12:00am
425
kok2fxrw dleiid7z
14 May 21
Business combination disclosure
4:06pm
S-4/A
EX-10.34
9vy fwrwq7
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4/A
g405 logsm6gjxi
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4
ay66peis2hp0j334
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
8-K
EX-2.1
b393cr7
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
425
EX-2.1
rejoi52j
8 Jan 21
Business combination disclosure
7:02am
10-K
utzh op2d
24 Mar 20
Annual report
12:00am
8-K
EX-1.1
b7itpy cnox
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm